Dr. Rebecca Salvo, DO

Dr. Salvo practices at Santa Barbara Endoscopy Center in Santa Barbara, California.

Dr. Salvo's NPI, 1457886566, was assigned on April 26, 2017. Dr. Salvo graduated from Pcom in 2017. Dr. Salvo holds California license 17359.

Dr. Salvo's primary practice is Santa Barbara Endoscopy Center, at 25 W Micheltorena St, Santa Barbara, CA 93101. The practice phone is (805) 966-1600.

Dr. Salvo's primary practice is Santa Barbara Endoscopy Center in Santa Barbara, California. Dr. Salvo is also affiliated with Santa Barbara Cottage Hospital. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Salvo to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salvo practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Salvo's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Salvo is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Salvo's licenses on file in 2 states: California and Nevada.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, hemorrhoids, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Salvo treats.

CMS data shows 1,341 Medicare services from Dr. Salvo across 17 procedure codes in 2024, for 736 Medicare patients. Medicare paid $135,673 for them.

CMS counts 736 Medicare patients who saw Dr. Salvo in 2024. The largest group is 65 to 74, with 378 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Salvo's median patient age at 63, with 64% women.

In 2024, Dr. Salvo wrote 404 Medicare Part D claims for 180 patients. 73% of them were for generic drugs. CMS names the drug for 264 of them, across 10 drugs with 11 or more claims each, at $166,998 in total drug cost. In 2023, CMS named 58 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Salvo for performance year 2024, reported as part of a group. Dr. Salvo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salvo as offering telehealth. CMS counts 413 procedures of colonoscopy by Dr. Salvo, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Salvo in 2018. 2018 was the busiest year, with 2. Dr. Salvo's most frequent co-authors are Vatinee Y. Bunya, MD, Nicole M. Fuerst, MD and Myron John Tong, MD.

CMS Open Payments shows 37 general payments to Dr. Salvo from 6 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $1,099.

Dr. Salvo graduated from Pcom in 2017. Dr. Salvo is a member of Sigma sigma phi.

Dr. Salvo is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.